Abstract:Reduced plasma adiponectin (APN) level not only contributes to the increased incidence of MI in diabetic patients, but also plays a causative role in increased cardiac injury after MI in these patients. However, singling mechanisms by which APN achieves its cardioprotection remains incompletely understood. Here, we investigated the role of AMP activated protein kinase (AMPK), the molecule that transfers APN’s metabolic signaling, in APN’s cardioprotection. Male adult mice with cardiac specific overexpression of a dominant negative AMPK α 2 subunit (AMPK-DN) or wild type (WT) littermates controls were subjected to 30 min of MI followed by reperfusion (R) and treated with vehicle (V) or globular domain of APN (gAPN, 2 μg/g) 10 min before R. Comparing with WT mice, MI/R caused greater cardiac injury including larger infarct size, more apoptosis and poorer cardiac function (P<0.05) in AMPK-DN mice. Treatment of WT mice with gAPN significantly attenuated MI/R injury (P<0.01). Most interestingly, although the metabolic regulatory effect of gAPN is completely lost in AMPK-DN mice, a significant portion of cardioprotection of gAPN retained in the transgenic animals. Specifically, treatment of AMPK-DN mice with gAPN reduced infarct size (54±4.7% vs. 81±3.6% in V group, P<0.01), decreased apoptosis (lesser TUNEL positive labeling, weaker DNA fragmentation, and lower caspase 3 activity. P value all <0.01) and improved cardiac function after MI/R (higher LVEF, lower LVEDP and higher dP/dt max . P value all <0.01). To further delineate the mechanisms responsible for gAPN’s AMPK-independent cardioprotection, effect of gAPN on cardiac oxidative/nitrative stress following MI/R were examined. Treatment of AMPK-DN mice with gAPN reduced superoxide and nitric oxide overproduction, decreased peroxynitrite formation (from 0.38±0.04 to 0.23±0.02 ng/mg protein in WT and from 0.50±0.06 to 0.32±0.02 ng/mg protein in AMPK-DN mice), and inhibited NADPH oxidase and iNOS expression to the same extent as that seen in WT mice. Taken together, our results demonstrated for the first time that a significant portion of gAPN cardioprotection is not mediated by the traditional AMPK signaling pathway and that the anti-oxidative/anti-nitrative effects of gAPN are AMPK-independent.

Abstract 342: Increased Myocardial Ischemic/Reperfusion Injury in Renal Failure Involves Cardiac Adiponectin Signal Deficiency

Increased Myocardial Ischemic/Reperfusion Injury in Renal Failure Involves Cardiac Adiponectin Signal Deficiency

Globular Domain Of Adiponectin Attenuates Post-Ischemia Myocardial Oxidative/Nitrative Stress In An Ampk-Independent Fashion

Adiponectin Knockout Accentuates High Fat Diet-Induced Obesity and Cardiac Dysfunction: Role of Autophagy

Cardioprotective Effect of Adiponectin is Partially Mediated by Its AMPK-independent Antinitrative Action.

Adiponectin Exerts Cardioprotection Against Ischemia/reperfusion Injury Partially Via Calreticulin Mediated Anti-Apoptotic and Anti-Oxidative Actions.

Adiponectin Deficiency Accentuates High Fat Diet‐Induced Cardiac Hypertrophy and Contractile Dysfunction Through Regulation of Autophagy

Adiponectin attenuates kidney injury and fibrosis in deoxycorticosterone acetate-salt and angiotensin II-induced CKD mice

Increased vascular permeability and severe renal tubular damage after ischemia-reperfusion injury in mice lacking adiponectin or T-cadherin

Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury.

Dynamic Alteration Of Adiponectin/Adiponectin Receptor Expression And Its Impact On Myocardial Ischemia/Reperfusion In Type 1 Diabetic Mice

Adiponectin Regulates SR Ca(2+) Cycling Following Ischemia/reperfusion Via Sphingosine 1-Phosphate-camkii Signaling in Mice.

ADAMTS13 Inhibits Oxidative Stress and Ameliorates Progressive Chronic Kidney Disease Following Ischaemia/reperfusion Injury.

Reduced Cardioprotective Action of Adiponectin in High-Fat Diet-Induced Type II Diabetic Mice and Its Underlying Mechanisms.

TNF-α Antagonism Ameliorates Myocardial Ischemia-Reperfusion Injury in Mice by Upregulating Adiponectin

Abstract P2012: GRK2-Induced Cardiomyocyte AdipoR1 Phosphorylation Blocks Adipocytes-Derived Exosomes Cardioprotection Against Ischemic Heart Failure

Adipocyte Na, K-ATPase Signaling Attenuates Experimental Uremic Cardiomyopathy

Amp-Activated Protein Kinase Deficiency Enhances Myocardial Ischemia/Reperfusion Injury But Has Minimal Effect On The Antioxidant/Antinitrative Protection Of Adiponectin

Adiponectin Cardioprotection After Myocardial Ischemia/Reperfusion Involves The Reduction Of Oxidative/Nitrative Stress

[OP.4D.02] ADIPONECTIN-MEDIATED EPITHILIAL AUTOPHAGY ATTENUATES HYPERTENSIVE RENAL FIBROSIS

Metabolism regulator adiponectin prevents cardiac remodeling and ventricular arrhythmias via sympathetic modulation in a myocardial infarction model